Disorder Related to Lung Transplantation
13
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
1 terminated out of 13 trials
90.0%
+3.5% vs benchmark
15%
2 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (13)
Prospective Evaluations of Infectious Complication in Lung Transplant Recipients
Hyperbaric Oxygen Therapy for Lung Transplantation
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients
Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)
Studying the Treatment Effect of Pirfenidone in Chronic Lung Allograft Dysfunction (STOP-CLAD)
Confocal Fluorescence Microscopy of the Human Airways in Diagnostics of Lung Transplantation
European Trial of Pirfenidone in BOS, A European Multi-center Study
Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung
Copenhagen Acute Renal Complications After Transplantations Study Group
Morphofunctional Lung Analysis by PET and CT After Lung Transplantation
Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation
QT-Prolongation in Lung Transplantation
Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation